UNICHEMLABNSEUnichem Laboratories Limited· PharmaceuticalsLowNeutral
Announced Fri, 3 Jul · 09:29 IST

Unichem Labs 63rd AGM on Aug 11, 2026; MD and CEO re-appointment on agenda

Board & Shareholder Meetings View source PDF

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.6%1-day move
₹466.95
prior close
₹466.85
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.4-1.6+2.5+22.6+40.3+36.1+23.8+15.3
Up moveDown movePending
AI summary

Unichem Laboratories has called its 63rd Annual General Meeting on Tuesday, August 11, 2026 at 3:30 PM via video conference. Agenda includes adoption of audited standalone and consolidated financial statements for FY ended March 31, 2026, re-appointment of Mr. Pabitrakumar Bhattacharyya as director retiring by rotation, and a special resolution to re-appoint him as MD and CEO for three more years from August 10, 2026 to August 9, 2029. Members will also ratify cost auditors Kishore Bhatia and Associates at Rs 6 lakh plus taxes for FY27. Remote e-voting runs from August 7 to August 10, 2026, with cut-off date of August 4, 2026. During his current tenure, standalone revenue grew 84 percent and formulation volumes rose 131 percent.

Likely market impact

Routine AGM filing. Re-appointment of MD and CEO ensures leadership continuity through a period being positioned for profitability improvement.